(Q28485323)

English

Application of a stochastic modeling to assess the evolution of tuberculous and non-tuberculous mycobacterial infection in patients treated with tumor necrosis factor inhibitors

scientific article

In more languages

Statements

scholarly article

0 references

Application of a stochastic modeling to assess the evolution of tuberculous and non-tuberculous mycobacterial infection in patients treated with tumor necrosis factor inhibitors (English)

0 references

5

0 references

author name string

Elena Agliari

1

0 references

Lorenzo Asti

2

0 references

Adriano Barra

3

0 references

Rossana Scrivo

4

0 references

Robert S Wallis

6

0 references

language of work or name

0 references

publication date

2013

0 references

0 references

8

0 references

1

0 references

e55017

0 references

copyright license

Creative Commons Attribution 4.0 International

28 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Advances in rheumatology: new targeted therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

19 March 2017

Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

19 March 2017

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

19 March 2017

TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

19 March 2017

Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Evolution of immune systems from self/not self to danger to artificial immune systems (AIS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Tumour necrosis factor antagonists: structure, function, and tuberculosis risks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Nontuberculous mycobacteria in the environment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Cytokine pathways and joint inflammation in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Estimation of the annual risk of tuberculosis infection for white men in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

The risk of tuberculous infection in The Netherlands from 1967 to 1979.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

29 September 2017

Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

2 June 2018

Granulomatous infectious diseases associated with tumor necrosis factor antagonists.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055017

21 January 2018

A case of tuberculous meningoencephalitis in a patient with Behçet's disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055017

21 January 2018

Can persistent Epstein-Barr virus infection induce chronic fatigue syndrome as a Pavlov reflex of the immune response?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055017

21 January 2018

A thermodynamic perspective of immune capabilities.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055017

21 January 2018

Serial interferon-γ release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055017

21 January 2018

Tuberculous peritonitis during infliximab therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557254

27 November 2018

Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23383039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/23383039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of nontuberculous mycobacterial lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23383039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycobacterial Interferon- Release Variations During Longterm Treatment with Tumor Necrosis Factor Blockers: Lack of Correlation with Clinical Outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23383039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23383039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exacerbation of tuberculosis enteritis after treatment with infliximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/23383039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0055017

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2013PLoSO...855017A

0 references

1 reference

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28485323&oldid=1865700858"